Tyreso, Sweden

Karin Ekberg

USPTO Granted Patents = 3 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Stockholm, SE (2011)
  • Tyreso, SE (2010 - 2013)

Company Filing History:


Years Active: 2010-2013

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Karin Ekberg

Introduction

Karin Ekberg is a notable inventor based in Tyreso, Sweden. She has made significant contributions to the field of diabetes treatment through her innovative patents. With a total of three patents to her name, her work focuses on improving the quality of life for individuals with diabetes.

Latest Patents

Karin's latest patents include "Methods and kits for preventing hypoglycemia" and "Therapeutic applications for C-peptide." The first patent describes improved methods and kits for treating the long-term complications of diabetes, specifically aimed at reducing the risk of hypoglycemia during C-peptide therapy. These methods not only help maintain good glycemic control but also prevent excessive weight gain that can result from high insulin administration or caloric intake. The second patent relates to the administration of C-peptide in a once-daily dose for the treatment of diabetes and its complications.

Career Highlights

Throughout her career, Karin has worked with various organizations, including Cebix Incorporated and La Jolla. Her innovative approaches have garnered attention in the medical community, particularly for their potential to enhance diabetes management.

Collaborations

Karin has collaborated with esteemed colleagues such as John Wahren and James Callaway, contributing to the advancement of diabetes treatment methodologies.

Conclusion

Karin Ekberg's contributions to diabetes treatment through her patents demonstrate her commitment to innovation in healthcare. Her work continues to impact the lives of many individuals living with diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…